1st ISIAT Symposium: Rome, 6-8 October 2011


Scientific Rationale for ISIAT 2011

Intra-articular treatments are emerging as promising tools for managing different kinds of articular and systemic diseases involving joints. Primary relevance was recently given to intra-articular administration of different compounds in pathologies such as osteoarthritis of different joints. The use of corticosteroids or hyaluronic acid for intra-articular administration is common in clinical practice and is supported by several data in scientific literature, confirming their efficacy and safety good profiles.
Nevertheless, many unanswered questions remain. ISIAT 2011, International symposium on intra-articular treatment, will gather all the experts in the field of intra-articular treatment from all over the world in order to analyze and eventually define future trends and studies on the most interesting topics that still need to be clarified.
A precise standardization of correct intra-articular administration procedures is still needed. The use of intra-articular therapy recently interested different joints and not only the commonly treated knee and shoulder. Hip, ankle, inter-phalangeal, tempuro-mandibular, sacro-iliac joints are always more frequently object of intra-articular therapy, as new image guidance tools are disposable for use in many clinics and hospitals. The use of ultrasound is also emerging as an excellent guidance tool for intra-articular administration of compounds and its use needs to be discussed and diffused. This is one of the most important issues for ISIAT 2011, as a large space for discussion will be given to such argument during the whole symposium.
The exact roles played by hyaluronans, hylans and corticosteroids, the most used compounds for intra-articular use, need to be better understood. Similarly, the emerging use of new compounds for intra-articular administration represents a very interesting step forward in this sector of clinical practice and all new drugs and compounds need to be studied in their efficacy, safety and cost-effectiveness profiles. A relevant part of ISIAT 2011 will be dedicated to the data sharing about all such compounds.
The use of intra-articular treatments in pathologies different from osteoarthritis, such as rheumatoid arthritis or other inflammatory joint diseases is also a new relevant object of study and discussion and will be largely analyzed during ISIAT 2011.
A large space will be dedicated to new horizons and perspectives in intra-articular treatments: in detail, new therapeutic targets, new diagnostic and prognostic factors, new delivery systems and new drugs will be discussed. Similarly, during ISIAT 2011, what clinicians need to improve and to develop for a better use of intra-articular therapies will be argument of discussion, with detailed analysis in the fields of pain medicine, osteoarthritis, sports medicine and for the management of inflammatory diseases, laying the foundations for new researches.
A space will be also dedicated to practical courses for intra-articular administration of therapeutic compounds in different joints. During ISIAT 2011 courses on intra-articular anatomy, physiopathology and intra-articular administration of therapeutic compounds for knee, shoulder, hip, ankle, sacro-iliac and metacarpo-phalangeal joints will be held by experts in the field.
ISIAT 2011 represents the first international, world-wide invitation for experts in the field of intra-articular treatments, the first occasion for discussing about such relevant arguments and will represent the basis for future studies.

Congress Chairman

Alberto Migliore
Director of Unit of Rheumatology
St. Peter Hospital and Center Research FBF – Rome, Italy
President of National Foundation of ultrasound guided Hip intra-articular Therapy (ANTIAGE)

Congress Co-Chairman 

Sandro Tormenta
Department of Diagnostic Imaging and Interventional Radiology – St. Peter Hospital FBF – Rome, Italy
Vice President of National Foundation of ultrasound guided Hip intra-articular Therapy (ANTIAGE)

Scientific Secretariat 

E. Bizzi
Unit of Rheumatology S. Peter Hospital and Center Research FBF – Rome, Italy

L.M. Sconfienza
Unit of Radiology – IRCCS Policlinico San Donato San Donato Milanese – Milan, Italy

Scientific Board

M. Granata
OU of Rheumatology San Filippo Neri Hospital, Rome, Italy

L.S. Martin
Dep of Internal Medicine Regina Apostolorum Hospital – Albano Laziale, Rome, Italy

E. Bizzi
OU of Rheumatology S. Pietro Fatebenefratelli Hospital – Rome, Italy


G. Abatangelo – Italy
M. Abate – Italy
L. Altomonte – Italy
M. Battaglia – Italy
G. Bianchi – Italy
E. Bizzi – Italy
H. Bliddal – Denmark
G. Boni – Italy
A.J. Boon – USA
L. Callegari – Italy
F. Ceccarelli – Italy
   X. Chevalier – France
S. Colen – Germany
G. Colini Baldeschi – Italy
T. Conrozier – France
M. Court-Payen – Denmark
O.De Lucia – Italy
A. De Marchi – Italy
A. Delle Sedie – Italy
L. Di Lorenzo – Italy
L. Di Matteo – Italy
F. Di Stani – Italy
   D. Diracoglu – Turkey
C.H. Evans – USA
S. Galletti – Italy
B. Gonçalves – Portugal
M. Granata – Italy
J. Gratacós – Spain
M. Guelfi – Italy
A. Harrison – England
G.D. Jay – USA
Y. Kosashvili – Istrael
D. Makrygiannakis – Sweden
   L.S. Martin – Italy
C. Martinoli – Italy
U. Massafra – Italy
G. Miceli – Italy
A. Migliore – Italy
G. Minisola – Italy
J. Natour – Brazil
G. Novelli – Italy
R.J. Petrella – Canada
P. Piscitelli – Italy
M.R. Povino – Italy
   R. Raman – England
M. Reijnierse – The Nederlands
J.J. Scali – Argentine
L.M. Sconfienza – Italy
G. Serafini – Italy
B. Steno – Slovakia
S. Tormenta – Italy
C.M. Ziegler – Norway


We would like to thank for their valuable support